Reshape ApS: Financial statements 2026
CVR: 40056173
Source: annual report 2026, Danish Business Authority
01/04/2025 – 31/03/2026
Reshape ApS (CVR 40056173) has filed annual accounts for 2026. In 2026, the company reported a gross profit of DKK 5,310,622 and a net result of DKK -42,643,506 compared with DKK -35,557,856 the year before. That is a decrease of 19.6% compared with the year before. Equity in the 2026 report amounted to DKK 75,515,117. The solvency ratio was 86%. The company had 56 employees in the financial year.
- Gross Profit
- DKK 5,310,622
- Profit/Loss
- DKK -42,643,506
- Equity
- DKK 75,515,117
- Total Assets
- DKK 87,778,096
- Employees
- 56
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2026 | - | 5.3 mio. | -42.6 mio. | 75.5 mio. | 56 |
| 2025 | - | 6.6 mio. | -35.6 mio. | 36.6 mio. | 51 |
| 2024 | - | 1.7 mio. | -12.2 mio. | 25.1 mio. | 18 |
| 2023 | - | 2 mio. | -4.6 mio. | 26.9 mio. | 10 |
| 2022 | - | -118 t. | -1.6 mio. | 5.5 mio. | 16 |
Official annual report
Find more companies like Reshape ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorAbout Reshape ApS
Reshape ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Carl-Emil Grøn Fuglesang, Daniel Storgaard and Magnus Nyborg Madsen. The company is owned by Reshape Biotech Inc.. According to the 2026 annual report, the company had an average of 56 employees. In 2026, the company reported a gross profit of DKK 5,310,622 and a net result of DKK -42,643,506 compared with DKK -35,557,856 the year before. Equity in the 2026 report amounted to DKK 75,515,117.